Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus

Antimicrobial resistance in bacteria has become a leading global public health issue. Staphylococcus sp. has an efficient mechanism to deal with antimicrobial agents that make them hard to treat in hospital-acquired and community-acquired infections. This study was conducted due to limited data abo...

Full description

Bibliographic Details
Main Authors: Cliff Clarence Haliman, Dimas Seto Prasetyo, Conny R Tjampakasari, Fera Ibrahim, T Mirawati Sudiro
Format: Article
Language:English
Published: Indonesian Society for Microbiology 2023-01-01
Series:Microbiology Indonesia
Online Access:https://jurnal.permi.or.id/index.php/mionline/article/view/1032
_version_ 1828057054610194432
author Cliff Clarence Haliman
Dimas Seto Prasetyo
Conny R Tjampakasari
Fera Ibrahim
T Mirawati Sudiro
author_facet Cliff Clarence Haliman
Dimas Seto Prasetyo
Conny R Tjampakasari
Fera Ibrahim
T Mirawati Sudiro
author_sort Cliff Clarence Haliman
collection DOAJ
description Antimicrobial resistance in bacteria has become a leading global public health issue. Staphylococcus sp. has an efficient mechanism to deal with antimicrobial agents that make them hard to treat in hospital-acquired and community-acquired infections. This study was conducted due to limited data about multidrug resistance and extensively drug resistance in Staphylococcus sp. in Indonesia. This study was a descriptive retrospective study using a cross-sectional design to get the prevalence and antimicrobial susceptibility of S. haemolyticus, S. aureus, and S. epidermidis. The data was secondary data extracted from WHONET 2022 software. This study’s data were from bacteria from samples sent to UKK LMK FKUI, Jakarta from 2017 to 2021 for routine diagnostic. In this study, we found that the prevalence of methicillin-resistant S.aureus was 24,9%, methicillin-resistant S.epidermidis was 65,5%, and methicillin-resistant S.haemolyticus was 86,8%. The prevalence of MDR S.aureus is less than S.epidermidis and S.haemolyticus, respectively. MDR S.haemolyticus was consistently above 85% each year, while S.epidermidis was above 50% and S.aureus was below 50%. XDR Staphylococcus was only found in S.aureus and S.haemolyticus, i.e. three and seven XDR isolates of S.aureus and S.haemolyticus respectively during 2017-2021. Although we could not find any pan-resistant isolates from all samples, we found methicillin-resistant S.aureus and S.haemolyticus isolates that were also resistant to vancomycin and linezolid. S.haemolyticus dan S. epidermidis were an important coagulase-negative Staphylococcus species that can’t be neglected due to the high percentage of MDR and the discoveries of XDR in S.haemolyticus so that they have the potential to disseminate resistance plasmids to the more virulent bacteria. Therefore we need to control the use of antimicrobial agent to prevent this resistance.
first_indexed 2024-04-10T21:05:13Z
format Article
id doaj.art-480bdfb935a14a28babee68923b2101c
institution Directory Open Access Journal
issn 1978-3477
2087-8575
language English
last_indexed 2024-04-10T21:05:13Z
publishDate 2023-01-01
publisher Indonesian Society for Microbiology
record_format Article
series Microbiology Indonesia
spelling doaj.art-480bdfb935a14a28babee68923b2101c2023-01-22T07:36:46ZengIndonesian Society for MicrobiologyMicrobiology Indonesia1978-34772087-85752023-01-0116210.5454/mi.16.2.15-23Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus Cliff Clarence Haliman0Dimas Seto Prasetyo1Conny R Tjampakasari2Fera Ibrahim3T Mirawati Sudiro4Program of Clinical Microbiology Residency, Faculty of Medicine, Universitas Indonesia, Jakarta 10320, IndonesiaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia- Cipto Mangunkusumo National Central General Hospital, Jakarta 10320, IndonesiaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia- Cipto Mangunkusumo National Central General Hospital, Jakarta 10320, IndonesiaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia- Cipto Mangunkusumo National Central General Hospital, Jakarta 10320, IndonesiaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia- Cipto Mangunkusumo National Central General Hospital, Jakarta 10320, Indonesia Antimicrobial resistance in bacteria has become a leading global public health issue. Staphylococcus sp. has an efficient mechanism to deal with antimicrobial agents that make them hard to treat in hospital-acquired and community-acquired infections. This study was conducted due to limited data about multidrug resistance and extensively drug resistance in Staphylococcus sp. in Indonesia. This study was a descriptive retrospective study using a cross-sectional design to get the prevalence and antimicrobial susceptibility of S. haemolyticus, S. aureus, and S. epidermidis. The data was secondary data extracted from WHONET 2022 software. This study’s data were from bacteria from samples sent to UKK LMK FKUI, Jakarta from 2017 to 2021 for routine diagnostic. In this study, we found that the prevalence of methicillin-resistant S.aureus was 24,9%, methicillin-resistant S.epidermidis was 65,5%, and methicillin-resistant S.haemolyticus was 86,8%. The prevalence of MDR S.aureus is less than S.epidermidis and S.haemolyticus, respectively. MDR S.haemolyticus was consistently above 85% each year, while S.epidermidis was above 50% and S.aureus was below 50%. XDR Staphylococcus was only found in S.aureus and S.haemolyticus, i.e. three and seven XDR isolates of S.aureus and S.haemolyticus respectively during 2017-2021. Although we could not find any pan-resistant isolates from all samples, we found methicillin-resistant S.aureus and S.haemolyticus isolates that were also resistant to vancomycin and linezolid. S.haemolyticus dan S. epidermidis were an important coagulase-negative Staphylococcus species that can’t be neglected due to the high percentage of MDR and the discoveries of XDR in S.haemolyticus so that they have the potential to disseminate resistance plasmids to the more virulent bacteria. Therefore we need to control the use of antimicrobial agent to prevent this resistance. https://jurnal.permi.or.id/index.php/mionline/article/view/1032
spellingShingle Cliff Clarence Haliman
Dimas Seto Prasetyo
Conny R Tjampakasari
Fera Ibrahim
T Mirawati Sudiro
Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus
Microbiology Indonesia
title Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus
title_full Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus
title_fullStr Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus
title_full_unstemmed Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus
title_short Multidrug Resistance and Extensively Drug-Resistance in Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus haemolyticus
title_sort multidrug resistance and extensively drug resistance in staphylococcus aureus staphylococcus epidermidis and staphylococcus haemolyticus
url https://jurnal.permi.or.id/index.php/mionline/article/view/1032
work_keys_str_mv AT cliffclarencehaliman multidrugresistanceandextensivelydrugresistanceinstaphylococcusaureusstaphylococcusepidermidisandstaphylococcushaemolyticus
AT dimassetoprasetyo multidrugresistanceandextensivelydrugresistanceinstaphylococcusaureusstaphylococcusepidermidisandstaphylococcushaemolyticus
AT connyrtjampakasari multidrugresistanceandextensivelydrugresistanceinstaphylococcusaureusstaphylococcusepidermidisandstaphylococcushaemolyticus
AT feraibrahim multidrugresistanceandextensivelydrugresistanceinstaphylococcusaureusstaphylococcusepidermidisandstaphylococcushaemolyticus
AT tmirawatisudiro multidrugresistanceandextensivelydrugresistanceinstaphylococcusaureusstaphylococcusepidermidisandstaphylococcushaemolyticus